Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
31.03
+1.69 (5.76%)
May 26, 2026, 4:00 PM EDT - Market closed
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.93 billion as of May 26, 2026. Its market cap has increased by 278.18% in one year.
Market Cap
1.93B
Enterprise Value
1.52B
1-Year Change
278.18%
Ranking
Category
Stock Price
$31.03
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.93B, an increase of 140.24%. That is a compound annual growth rate of 13.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 1.93B | 6.60% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 1.87B |
| Generate Biomedicines | 1.86B |
| Sionna Therapeutics | 1.86B |
| Iovance Biotherapeutics | 1.84B |
| Lakefront Biotherapeutics NV | 1.82B |
| Nurix Therapeutics | 1.81B |
| Rapport Therapeutics | 1.80B |
| Ocular Therapeutix | 1.80B |